HuGE Literature Finder
|
||
Records 1-100
|
Gene mutation profile and risk stratification in AML1-ETO-positive acute myeloid leukemia based on next-generation sequencing.
Oncology reports 2019 Oct . Yu Guopan, Yin Changxin, Wu Fuqun, Jiang Ling, Zheng Zhongxin, Xu Dan, Zhou Jiaheng, Jiang Xuejie, Liu Qifa, Meng Fan |
|
Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern.
Blood advances 2019 Oct 3 (20): 3111-3122. Berger Gerbrig, Gerritsen Mylene, Yi Guoqiang, Koorenhof-Scheele Theresia N, Kroeze Leonie I, Stevens-Kroef Marian, Yoshida Kenichi, Shiraishi Yuichi, van den Berg Eva, Schepers Hein, Huls Geert, Mulder André B, Ogawa Seishi, Martens Joost H A, Jansen Joop H, Vellenga E |
|
[Mutation analysis of 77 patients with normal-karyotype myelodysplastic syndrome].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2019 Sep 36 (9): 857-861. Qin Wei, Chen Meiyu, Cai Xiaohui, Chao Hongying, Liu Jie, Jiang Naike, Zhou Min, Lu Xuzhang, Chen Suning, Zhang Ri, He Chuan, Wang Qi |
|
Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation.
Bone marrow transplantation 2019 Aug 54 (8): 1189-1197. Grimm Juliane, Bill Marius, Jentzsch Madlen, Beinicke Stefanie, Häntschel Janine, Goldmann Karoline, Schulz Julia, Cross Michael, Franke Georg-Nikolaus, Behre Gerhard, Vucinic Vladan, Pönisch Wolfram, Lange Thoralf, Niederwieser Dietger, Schwind Sebasti |
|
Targeted sequencing aids in identifying clonality in chronic myelomonocytic leukemia.
Leukemia research 2019 Jul 84 106190. Hwang Sang Mee, Kim Sung-Min, Nam Youngwon, Kim Jinhyun, Kim Sungsik, Ahn Yong-Oon, Park Yong, Yoon Sung-Soo, Shin Sue, Kwon Sunghoon, Lee Dong So |
|
Importance of prognostic stratification via gene mutation analysis in elderly patients with acute myelogenous leukemia.
International journal of laboratory hematology 2019 Apr . Fujiwara Yusuke, Yamaguchi Hiroki, Yui Shunsuke, Tokura Taichiro, Inai Kazuki, Onai Daishi, Omori Ikuko, Marumo Atsushi, Yamanaka Satoshi, Sakaguchi Masahiro, Terada Kazuki, Nakagome Shun, Arai Kunihito, Kitano Tomoaki, Okabe Masahiro, Okamoto Muneo, Tamai Hayato, Nakayama Kazutaka, Tajika Kenji, Wakita Satoshi, Inokuchi Koi |
|
Myeloid malignancies with isolated 7q deletion can be further characterized by their accompanying molecular mutations.
Genes, chromosomes & cancer 2019 Apr . Hartmann Luise, Haferlach Claudia, Meggendorfer Manja, Kern Wolfgang, Haferlach Torsten, Stengel An |
|
Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes.
Leukemia 2019 Feb . Follo Matilde Y, Pellagatti Andrea, Armstrong Richard N, Ratti Stefano, Mongiorgi Sara, De Fanti Sara, Bochicchio Maria Teresa, Russo Domenico, Gobbi Marco, Miglino Maurizio, Parisi Sarah, Martinelli Giovanni, Cavo Michele, Luiselli Donata, McCubrey James A, Suh Pann-Ghill, Manzoli Lucia, Boultwood Jacqueline, Finelli Carlo, Cocco Luc |
|
Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia.
Annals of laboratory medicine 2018 Nov 38 (6): 495-502. Kim Hyun Young, Lee Ki O, Park Silvia, Jang Jun Ho, Jung Chul Won, Kim Sun Hee, Kim Hee J |
|
Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management.
American journal of hematology 2018 Aug 93 (4): 578-587. Elliott Michelle A, Tefferi Ayal |
|
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high risk disease.
Blood 2018 Jul . Branford Susan, Wang Paul, Yeung David T, Thomson Daniel, Purins Adrian, Wadham Carol, Shahrin Nur Hezrin, Marum Justine E, Nataren Nathalie, Parker Wendy T, Geoghegan Joel, Feng Jinghua, Shanmuganathan Naranie, Mueller Martin C, Dietz Christian, Stangl Doris, Donaldson Zoe, Altamura Haley, Georgievski Jasmina, Braley Jodi, Brown Anna, Hahn Christopher, Walker Ieuan, Kim Soo-Hyun, Choi Soo-Young, Park Sa-Hee, Kim Dong-Wook, White Deborah L, Yong Agnes S M, Ross David M, Scott Hamish S, Schreiber Andreas W, Hughes Timothy |
|
Molecular Markers and Prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis.
Clinical lymphoma, myeloma & leukemia 2018 Jun . Lee Yen-Chien, Hsieh Chung-Cheng, Lee Yen-Ling, Li Chung- |
|
ASXL1 mutations in Chinese patients with essential thrombocythemia.
Experimental and therapeutic medicine 2018 May 15 (5): 4149-4156. Nie Yan-Bo, Sun Meng, He Colin K, Ju Man-Kai, Zhou Fu-Ling, Wu San-Yun, Zhou Yi, Liu Li, Shen Hui, Huang Ting-Ting, Liu Pan, Xu Ying, Shao Liang, Zuo Xue-L |
|
Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Apr JCO2017776757. Morita Kiyomi, Kantarjian Hagop M, Wang Feng, Yan Yuanqing, Bueso-Ramos Carlos, Sasaki Koji, Issa Ghayas C, Wang Sa, Jorgensen Jeffrey, Song Xingzhi, Zhang Jianhua, Tippen Samantha, Thornton Rebecca, Coyle Marcus, Little Latasha, Gumbs Curtis, Pemmaraju Naveen, Daver Naval, DiNardo Courtney D, Konopleva Marina, Andreeff Michael, Ravandi Farhad, Cortes Jorge E, Kadia Tapan, Jabbour Elias, Garcia-Manero Guillermo, Patel Keyur P, Futreal P Andrew, Takahashi Koic |
|
Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.
Blood cancer journal 2018 Apr 8 (4): 39. Hou Hsin-An, Tsai Cheng-Hong, Lin Chien-Chin, Chou Wen-Chien, Kuo Yuan-Yeh, Liu Chieh-Yu, Tseng Mei-Hsuan, Peng Yen-Ling, Liu Ming-Chih, Liu Chia-Wen, Liao Xiu-Wen, Lin Liang-In, Yao Ming, Tang Jih-Luh, Tien Hwei-Fa |
|
Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents.
EBioMedicine 2018 Apr . Duchmann Matthieu, Yalniz Fevzi F, Sanna Alessandro, Sallman David, Coombs Catherine C, Renneville Aline, Kosmider Olivier, Braun Thorsten, Platzbecker Uwe, Willems Lise, Adès Lionel, Fontenay Michaela, Rampal Raajit, Padron Eric, Droin Nathalie, Preudhomme Claude, Santini Valeria, Patnaik Mrinal M, Fenaux Pierre, Solary Eric, Itzykson Rapha |
|
Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
The New England journal of medicine 2018 Mar 378 (13): 1189-1199. Jongen-Lavrencic Mojca, Grob Tim, Hanekamp Diana, Kavelaars François G, Al Hinai Adil, Zeilemaker Annelieke, Erpelinck-Verschueren Claudia A J, Gradowska Patrycja L, Meijer Rosa, Cloos Jacqueline, Biemond Bart J, Graux Carlos, van Marwijk Kooy Marinus, Manz Markus G, Pabst Thomas, Passweg Jakob R, Havelange Violaine, Ossenkoppele Gert J, Sanders Mathijs A, Schuurhuis Gerrit J, Löwenberg Bob, Valk Peter J |
|
ASXL1 mutations in AML are associated with specific clinical and cytogenetic characteristics.
Leukemia & lymphoma 2018 Feb 1-8. Kakosaiou Katerina, Panitsas Fotios, Daraki Aggeliki, Pagoni Maria, Apostolou Paraskevi, Ioannidou Agapi, Vlachadami Ioanna, Marinakis Theodoros, Giatra Chara, Vasilatou Diamantina, Sambani Constantina, Pappa Vassiliki, Manola Kalliopi |
|
Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.
Leukemia 2018 Feb . Rothenberg-Thurley Maja, Amler Susanne, Goerlich Dennis, Köhnke Thomas, Konstandin Nikola P, Schneider Stephanie, Sauerland Maria C, Herold Tobias, Hubmann Max, Ksienzyk Bianka, Zellmeier Evelyn, Bohlander Stefan K, Subklewe Marion, Faldum Andreas, Hiddemann Wolfgang, Braess Jan, Spiekermann Karsten, Metzeler Klaus |
|
Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosis.
Genes, chromosomes & cancer 2018 Jan . Naumann Nicole, Jawhar Mohamad, Schwaab Juliana, Kluger Sebastian, Lübke Johannes, Metzgeroth Georgia, Popp Henning D, Khaled Nada, Horny Hans-Peter, Sotlar Karl, Valent Peter, Haferlach Claudia, Göhring Gudrun, Schlegelberger Brigitte, Meggendorfer Manja, Hofmann Wolf-Karsten, Cross Nicholas C P, Reiter Andreas, Fabarius Ali |
|
Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1.
Blood cancer journal 2018 Jan 8 (1): 4. Saygin Caner, Hirsch Cassandra, Przychodzen Bartlomiej, Sekeres Mikkael A, Hamilton Betty K, Kalaycio Matt, Carraway Hetty E, Gerds Aaron T, Mukherjee Sudipto, Nazha Aziz, Sobecks Ronald, Goebel Christopher, Abounader Donna, Maciejewski Jaroslaw P, Advani Anjali |
|
Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.
Leukemia 2017 Dec . Rothenberg-Thurley M, Amler S, Goerlich D, Köhnke T, Konstandin N P, Schneider S, Sauerland M C, Herold T, Hubmann M, Ksienzyk B, Zellmeier E, Bohlander S K, Subklewe M, Faldum A, Hiddemann W, Braess J, Spiekermann K, Metzeler K |
|
Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patients.
American journal of hematology 2017 Nov . Tefferi Ayalew, Nicolosi Maura, Mudireddy Mythri, Szuber Natasha, Finke Christy M, Lasho Terra L, Hanson Curtis A, Ketterling Rhett P, Pardanani Animesh, Gangat Naseema, Mannarelli Carmela, Fanelli Tiziana, Guglielmelli Paola, Vannucchi Alessandro |
|
Genetic variations of bone marrow mesenchymal stromal cells derived from acute leukemia and myelodysplastic syndrome by targeted deep sequencing.
Leukemia research 2017 Sep 62 23-28. Azuma Kenko, Umezu Tomohiro, Imanishi Satoshi, Asano Michiyo, Yoshizawa Seiichiro, Katagiri Seiichiro, Ohyashiki Kazuma, Ohyashiki Junko |
|
Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R.
American journal of hematology 2017 Sep . Tefferi Ayalew, Lasho Terra L, Patnaik Mrinal M, Saeed Lyla, Mudireddy Mythri, Idossa Dame, Finke Christy, Ketterling Rhett P, Pardanani Animesh, Gangat Nasee |
|
ASXL1 and BIM germ line variants predict response and identify CML patients with the greatest risk of imatinib failure.
Blood advances 2017 Aug 1 (18): 1369-1381. Marum Justine E, Yeung David T, Purins Leanne, Reynolds John, Parker Wendy T, Stangl Doris, Wang Paul P S, Price David J, Tuke Jonathan, Schreiber Andreas W, Scott Hamish S, Hughes Timothy P, Branford Sus |
|
CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabine.
Leukemia & lymphoma 2017 Jul 1-8. Allan John N, Roboz Gail J, Askin Gulce, Ritchie Ellen, Scandura Joseph, Christos Paul, Hassane Duane C, Guzman Monica |
|
Clinical Outcomes and Co-Occurring Mutations in Patients with RUNX1-Mutated Acute Myeloid Leukemia.
International journal of molecular sciences 2017 Jul 18 (8): . Khan Maliha, Cortes Jorge, Kadia Tapan, Naqvi Kiran, Brandt Mark, Pierce Sherry, Patel Keyur P, Borthakur Gautam, Ravandi Farhad, Konopleva Marina, Kornblau Steven, Kantarjian Hagop, Bhalla Kapil, DiNardo Courtney |
|
Comparison of the Mutational Profiles of Primary Myelofibrosis, Polycythemia Vera, and Essential Thrombocytosis.
American journal of clinical pathology 2017 May 147 (5): 444-452. Song Jinming, Hussaini Mohammad, Zhang Hailing, Shao Haipeng, Qin Dahui, Zhang Xiaohui, Ma Zhenjun, Hussnain Naqvi Syeda Mahrukh, Zhang Ling, Moscinski Lynn |
|
Clinical significance of somatic mutation in unexplained blood cytopenia.
Blood 2017 Apr . Malcovati Luca, Gallì Anna, Travaglino Erica, Ambaglio Ilaria, Rizzo Ettore, Molteni Elisabetta, Elena Chiara, Ferretti Virginia Valeria, Catricalà Silvia, Bono Elisa, Todisco Gabriele, Bianchessi Antonio, Rumi Elisa, Zibellini Silvia, Pietra Daniela, Boveri Emanuela, Camaschella Clara, Toniolo Daniela, Papaemmanuil Elli, Ogawa Seishi, Cazzola Mar |
|
Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia.
Blood cancer journal 2017 Apr 7 (4): e559. Togasaki E, Takeda J, Yoshida K, Shiozawa Y, Takeuchi M, Oshima M, Saraya A, Iwama A, Yokote K, Sakaida E, Hirase C, Takeshita A, Imai K, Okumura H, Morishita Y, Usui N, Takahashi N, Fujisawa S, Shiraishi Y, Chiba K, Tanaka H, Kiyoi H, Ohnishi K, Ohtake S, Asou N, Kobayashi Y, Miyazaki Y, Miyano S, Ogawa S, Matsumura I, Nakaseko C, Naoe |
|
Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia.
American journal of hematology 2017 Mar . Patnaik Mrinal M, Barraco Daniela, Lasho Terra L, Finke Christy M, Reichard Kaaren, Hoversten Katherine P, Ketterling Rhett P, Gangat Naseema, Tefferi Ayal |
|
[The clinical characteristics, gene mutations and prognosis of chronic neutrophilic leukemia].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2017 Jan 38 (1): 28-32. Cui Y J, Jiang Q, Liu J Q, Li B, Xu Z F, Qin T J, Zhang Y, Cai W Y, Zhang H L, Fang L W, Pan L J, Hu N B, Qu S Q, Xiao Z |
|
ASXL2 Mutations are Frequently Found in Pediatric AML Patients with t(8;21)/RUNX1-RUNX1T1 and Associated with a Better Prognosis.
Genes, chromosomes & cancer 2017 Jan . Yamato Genki, Shiba Norio, Yoshida Kenichi, Shiraishi Yuichi, Hara Yusuke, Ohki Kentaro, Okubo Jun, Okuno Haruna, Chiba Kenichi, Tanaka Hiroko, Kinoshita Akitoshi, Moritake Hiroshi, Kiyokawa Nobutaka, Tomizawa Daisuke, Park Myoung-Ja, Sotomatsu Manabu, Taga Takashi, Adachi Souichi, Tawa Akio, Horibe Keizo, Arakawa Hirokazu, Miyano Satoru, Ogawa Seishi, Hayashi Yasuhi |
|
ASXL1 mutations are frequent in de novo AML with trisomy 8 and confer an unfavorable prognosis.
Leukemia & lymphoma 2016 Oct 1-3. Zong Xiangping, Yao Hong, Wen Lijun, Ma Liang, Wang Qinrong, Yang Zhiluo, Zhang Tongtong, Chen Suning, Depei |
|
DNMT3A Mutations are Associated with Inferior Overall and Leukemia-free Survival in Chronic Myelomonocytic Leukemia.
American journal of hematology 2016 Oct . Patnaik Mrinal M, Barraco Daniela, Lasho Terra L, Finke Christy M, Hanson Curtis A, Ketterling Rhett P, Gangat Naseema, Tefferi Ayal |
|
ASXL1 and JAK2V617F gene mutation screening in Iranian patients with chronic myeloid leukemia.
Asia-Pacific journal of clinical oncology 2016 Sep . Valikhani Amir, Poopak Behzad, Ferdowsi Shirin, Azizi Tabesh Ghasem, Ghaffari Seyed H, Saraf Kazeruoni Ehsan, Rezaei Negar, Farshchi Alireza, Amirizadeh Nas |
|
Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Sep . Della Porta Matteo G, Gallì Anna, Bacigalupo Andrea, Zibellini Silvia, Bernardi Massimo, Rizzo Ettore, Allione Bernardino, van Lint Maria Teresa, Pioltelli Pietro, Marenco Paola, Bosi Alberto, Voso Maria Teresa, Sica Simona, Cuzzola Mariella, Angelucci Emanuele, Rossi Marianna, Ubezio Marta, Malovini Alberto, Limongelli Ivan, Ferretti Virginia V, Spinelli Orietta, Tresoldi Cristina, Pozzi Sarah, Luchetti Silvia, Pezzetti Laura, Catricalà Silvia, Milanesi Chiara, Riva Alberto, Bruno Benedetto, Ciceri Fabio, Bonifazi Francesca, Bellazzi Riccardo, Papaemmanuil Elli, Santoro Armando, Alessandrino Emilio P, Rambaldi Alessandro, Cazzola Mar |
|
Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia.
British journal of haematology 2016 Aug . Bhatnagar Bhavana, Eisfeld Ann-Kathrin, Nicolet Deedra, Mrózek Krzysztof, Blachly James S, Orwick Shelley, Lucas David M, Kohlschmidt Jessica, Blum William, Kolitz Jonathan E, Stone Richard M, Bloomfield Clara D, Byrd John |
|
Human blood cell levels of 5-hydroxymethylcytosine (5hmC) decline with age, partly related to acquired mutations in TET2.
Experimental hematology 2016 Jul . Buscarlet Manuel, Tessier Alain, Provost Sylvie, Mollica Luigina, Busque Lambe |
|
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.
Blood 2016 Jul . Elena Chiara, Gallì Anna, Such Esperanza, Meggendorfer Manja, Germing Ulrich, Rizzo Ettore, Cervera Jose, Molteni Elisabetta, Fasan Annette, Schuler Esther, Ambaglio Ilaria, Lopez-Pavia Maria, Zibellini Silvia, Kuendgen Andrea, Travaglino Erica, Sancho-Tello Reyes, Catricalà Silvia, Vicente Ana I, Haferlach Torsten, Haferlach Claudia, Sanz Guillermo F, Malcovati Luca, Cazzola Mar |
|
Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis.
Leukemia 2016 Jul . Jawhar M, Schwaab J, Hausmann D, Clemens J, Naumann N, Henzler T, Horny H-P, Sotlar K, Schoenberg S O, Cross N C P, Fabarius A, Hofmann W-K, Valent P, Metzgeroth G, Reiter |
|
Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features.
Oncotarget 2016 Jul . Palomo Laura, Garcia Olga, Arnan Montse, Xicoy Blanca, Fuster Francisco, Cabezón Marta, Coll Rosa, Ademà Vera, Grau Javier, Jiménez Maria-José, Pomares Helena, Marcé Sílvia, Mallo Mar, Millá Fuensanta, Alonso Esther, Sureda Anna, Gallardo David, Feliu Evarist, Ribera Josep-Maria, Solé Francesc, Zamora Lurd |
|
Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia.
British journal of haematology 2016 Jul . Shiba Norio, Yoshida Kenichi, Shiraishi Yuichi, Okuno Yusuke, Yamato Genki, Hara Yusuke, Nagata Yasunobu, Chiba Kenichi, Tanaka Hiroko, Terui Kiminori, Kato Motohiro, Park Myoung-Ja, Ohki Kentaro, Shimada Akira, Takita Junko, Tomizawa Daisuke, Kudo Kazuko, Arakawa Hirokazu, Adachi Souichi, Taga Takashi, Tawa Akio, Ito Etsuro, Horibe Keizo, Sanada Masashi, Miyano Satoru, Ogawa Seishi, Hayashi Yasuhi |
|
Mutation profiling of 19 candidate genes in acute myeloid leukemia suggests significance of DNMT3A mutations.
Oncotarget 2016 Jun . Shin Sang-Yong, Lee Seung-Tae, Kim Hee-Jin, Cho Eun Hae, Kim Jong-Won, Park Silvia, Jung Chul Won, Kim Sun-H |
|
Subtype-specific patterns of molecular mutations in acute myeloid leukemia.
Leukemia 2016 Jun . Rose D, Haferlach T, Schnittger S, Perglerová K, Kern W, Haferlach |
|
CTNNA1 hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcome.
Oncotarget 2016 May 7 (21): 31454-65. Li Mianyang, Gao Li, Li Zhenling, Sun Junzhong, Zhang Hui, Duan Haoqing, Ma Yigai, Wang Chengb |
|
EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia.
Journal of cancer research and clinical oncology 2016 May . Schäfer Vivien, Ernst Jana, Rinke Jenny, Winkelmann Nils, Beck James F, Hochhaus Andreas, Gruhn Bernd, Ernst Thom |
|
Next-generation sequencing in systemic mastocytosis: Derivation of a mutation-augmented clinical prognostic model for survival.
American journal of hematology 2016 May . Pardanani Animesh, Lasho Terra, Elala Yoseph, Wassie Emnet, Finke Christy, Reichard Kaaren K, Chen Dong, Hanson Curtis A, Ketterling Rhett P, Tefferi Ayal |
|
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features.
Leukemia 2016 May . Gaidzik V I, Teleanu V, Papaemmanuil E, Weber D, Paschka P, Hahn J, Wallrabenstein T, Kolbinger B, Köhne C-H, Horst H A, Brossart P, Held G, Kündgen A, Ringhoffer M, Götze K, Rummel M, Gerstung M, Campbell P, Kraus J M, Kestler H A, Thol F, Heuser M, Schlegelberger B, Ganser A, Bullinger L, Schlenk R F, Döhner K, Döhner |
|
Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 May . Wang Sa A, Tam Wayne, Tsai Albert G, Arber Daniel A, Hasserjian Robert P, Geyer Julia T, George Tracy I, Czuchlewski David R, Foucar Kathryn, Rogers Heesun J, Hsi Eric D, Bryan Rea B, Bagg Adam, Dal Cin Paola, Zhao Chong, Kelley Todd W, Verstovsek Srdan, Bueso-Ramos Carlos, Orazi Attil |
|
Clonal hematopoiesis in acquired aplastic anemia.
Blood 2016 Apr . Ogawa Seis |
|
Genetic alterations and their clinical implications in older patients with acute myeloid leukemia.
Leukemia 2016 Mar . Tsai C-H, Hou H-A, Tang J-L, Liu C-Y, Lin C-C, Chou W-C, Tseng M-H, Chiang Y-C, Kuo Y-Y, Liu M-C, Liu C-W, Lin L-I, Tsay W, Yao M, Li C-C, Huang S-Y, Ko B-S, Hsu S-C, Chen C-Y, Lin C-T, Wu S-J, Tien H |
|
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia.
Oncotarget 2016 Jan . Hou Hsin-An, Liu Chieh-Yu, Kuo Yuan-Yeh, Chou Wen-Chien, Tsai Cheng-Hong, Lin Chien-Chin, Lin Liang-In, Tseng Mei-Hsuan, Chiang Ying-Chieh, Liu Ming-Chih, Liu Chia-Wen, Tang Jih-Luh, Yao Ming, Li Chi-Cheng, Huang Shang-Yi, Ko Bor-Sheng, Hsu Szu-Chun, Chen Chien-Yuan, Lin Chien-Ting, Wu Shang-Ju, Tsay Woei, Tien Hwei-Fa |
|
A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid Leukemia.
PloS one 2016 11 (4): e0153016. Sloan Caroline E, Luskin Marlise R, Boccuti Anne M, Sehgal Alison R, Zhao Jianhua, Daber Robert D, Morrissette Jennifer J D, Luger Selina M, Bagg Adam, Gimotty Phyllis A, Carroll Mart |
|
Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia.
Blood cancer journal 2016 6 e385. Patnaik M M, Lasho T L, Vijayvargiya P, Finke C M, Hanson C A, Ketterling R P, Gangat N, Tefferi |
|
Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic Trioxide.
EBioMedicine 2015 Jun 2 (6): 563-71. Shen Yang, Fu Ya-Kai, Zhu Yong-Mei, Lou Yin-Jun, Gu Zhao-Hui, Shi Jing-Yi, Chen Bing, Chen Chao, Zhu Hong-Hu, Hu Jiong, Zhao Wei-Li, Mi Jian-Qing, Chen Li, Zhu Hong-Ming, Shen Zhi-Xiang, Jin Jie, Wang Zhen-Yi, Li Jun-Min, Chen Zhu, Chen Sai-Ju |
|
Blast transformation in chronic myelomonocytic leukemia: Risk factors, genetic features, survival, and treatment outcome.
American journal of hematology 2015 May 90 (5): 411-6. Patnaik Mrinal M, Wassie Emnet A, Lasho Terra L, Hanson Curtis A, Ketterling Rhett, Tefferi Ayal |
|
Integrated genomic profiling, therapy response, and survival in adult acute myelogenous leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2015 May 21 (9): 2045-56. Parkin Brian, Ouillette Peter, Yildiz Mehmet, Saiya-Cork Kamlai, Shedden Kerby, Malek Sami |
|
Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2015 May 28 (5): 706-14. Ohgami Robert S, Ma Lisa, Merker Jason D, Gotlib Jason R, Schrijver Iris, Zehnder James L, Arber Daniel |
|
ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study Group.
Haematologica 2015 Mar 100 (3): 324-30. Paschka Peter, Schlenk Richard F, Gaidzik Verena I, Herzig Julia K, Aulitzky Teresa, Bullinger Lars, Späth Daniela, Teleanu Veronika, Kündgen Andrea, Köhne Claus-Henning, Brossart Peter, Held Gerhard, Horst Heinz-A, Ringhoffer Mark, Götze Katharina, Nachbaur David, Kindler Thomas, Heuser Michael, Thol Felicitas, Ganser Arnold, Döhner Hartmut, Döhner Konstan |
|
Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation.
European journal of haematology 2015 Mar . Peng Jie, Zuo Zhuang, Fu Bin, Oki Yasuhiro, Tang Guilin, Goswami Maitrayee, Priyanka Priyanka, Muzzafar Tariq, Medeiros L Jeffrey, Luthra Rajyalakshmi, Wang Sa |
|
WT1 mutations are secondary events in AML, show varying frequencies and impact on prognosis between genetic subgroups.
Leukemia 2015 Mar 29 (3): 660-7. Krauth M-T, Alpermann T, Bacher U, Eder C, Dicker F, Ulke M, Kuznia S, Nadarajah N, Kern W, Haferlach C, Haferlach T, Schnittger |
|
Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome.
Blood cancer journal 2015 5 e270. Patnaik M M, Wassie E A, Padron E, Onida F, Itzykson R, Lasho T L, Kosmider O, Finke C M, Hanson C A, Ketterling R P, Komrokji R, Tefferi A, Solary |
|
Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes.
Nature communications 2015 6 5901. Gerstung Moritz, Pellagatti Andrea, Malcovati Luca, Giagounidis Aristoteles, Porta Matteo G Della, Jädersten Martin, Dolatshad Hamid, Verma Amit, Cross Nicholas C P, Vyas Paresh, Killick Sally, Hellström-Lindberg Eva, Cazzola Mario, Papaemmanuil Elli, Campbell Peter J, Boultwood Jacqueli |
|
Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia.
Experimental hematology & oncology 2015 4 14. Cui Yajuan, Tong Hongyan, Du Xin, Li Bing, Gale Robert Peter, Qin Tiejun, Liu Jinqin, Xu Zefeng, Zhang Yue, Huang Gang, Jin Jie, Fang Liwei, Zhang Hongli, Pan Lijuan, Hu Naibo, Qu Shiqiang, Xiao Zhiji |
|
Prognostic significance of ASXL1, JAK2V617F mutations and JAK2V617F allele burden in Philadelphia-negative myeloproliferative neoplasms.
Journal of blood medicine 2015 6 157-75. Yonal-Hindilerden Ipek, Daglar-Aday Aynur, Akadam-Teker Basak, Yilmaz Ceylan, Nalcaci Meliha, Yavuz Akif Selim, Sargin Den |
|
CALR mutation screening in pediatric primary myelofibrosis.
Pediatric blood & cancer 2014 Dec 61 (12): 2256-62. An Wenbin, Wan Yang, Guo Ye, Chen Xiaojuan, Ren Yuanyuan, Zhang Jingliao, Chang Lixian, Wei Wei, Zhang Peihong, Zhu Xiaof |
|
ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients.
Leukemia 2014 Nov 28 (11): 2206-12. Patnaik M M, Itzykson R, Lasho T L, Kosmider O, Finke C M, Hanson C A, Knudson R A, Ketterling R P, Tefferi A, Solary |
|
Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.
Blood 2014 Oct 124 (16): 2596-606. Pidala Joseph, Lee Stephanie J, Ahn Kwang Woo, Spellman Stephen, Wang Hai-Lin, Aljurf Mahmoud, Askar Medhat, Dehn Jason, Fernandez Viña Marcelo, Gratwohl Alois, Gupta Vikas, Hanna Rabi, Horowitz Mary M, Hurley Carolyn K, Inamoto Yoshihiro, Kassim Adetola A, Nishihori Taiga, Mueller Carlheinz, Oudshoorn Machteld, Petersdorf Effie W, Prasad Vinod, Robinson James, Saber Wael, Schultz Kirk R, Shaw Bronwen, Storek Jan, Wood William A, Woolfrey Ann E, Anasetti Claud |
|
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients.
Leukemia 2014 Sep 28 (9): 1804-10. Guglielmelli P, Lasho T L, Rotunno G, Score J, Mannarelli C, Pancrazzi A, Biamonte F, Pardanani A, Zoi K, Reiter A, Duncombe A, Fanelli T, Pietra D, Rumi E, Finke C, Gangat N, Ketterling R P, Knudson R A, Hanson C A, Bosi A, Pereira A, Manfredini R, Cervantes F, Barosi G, Cazzola M, Cross N C P, Vannucchi A M, Tefferi |
|
High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcome.
Leukemia 2014 Jul 28 (7): 1449-58. Krauth M-T, Eder C, Alpermann T, Bacher U, Nadarajah N, Kern W, Haferlach C, Haferlach T, Schnittger |
|
TET2 gene mutation is unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients with NPM1+ and FLT3-ITD - mutations.
International journal of hematology 2014 Jul 100 (1): 96-104. Tian Xiaopeng, Xu Yang, Yin Jia, Tian Hong, Chen Suning, Wu Depei, Sun Aini |
|
ASXL1 mutations are infrequent in young patients with primary acute myeloid leukemia and their detection has a limited role in therapeutic risk stratification.
Leukemia & lymphoma 2014 Jun 55 (6): 1326-31. El-Sharkawi Dima, Ali Akbar, Evans Catherine M, Hills Robert K, Burnett Alan K, Linch David C, Gale Rosemary |
|
Gene mutation patterns in patients with minimally differentiated acute myeloid leukemia.
Neoplasia (New York, N.Y.) 2014 Jun 16 (6): 481-8. Kao Hsiao-Wen, Liang Der-Cherng, Wu Jin-Hou, Kuo Ming-Chung, Wang Po-Nan, Yang Chao-Ping, Shih Yu-Shu, Lin Tung-Huei, Huang Yu-Hui, Shih Lee-Yu |
|
The role of different genetic subtypes of CEBPA mutated AML.
Leukemia 2014 Apr 28 (4): 794-803. Fasan A, Haferlach C, Alpermann T, Jeromin S, Grossmann V, Eder C, Weissmann S, Dicker F, Kohlmann A, Schindela S, Kern W, Haferlach T, Schnittger |
|
Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation.
Haematologica 2014 Feb 99 (2): 276-81. West Robert R, Hsu Amy P, Holland Steven M, Cuellar-Rodriguez Jennifer, Hickstein Dennis |
|
Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trial.
Oncotarget 2014 Feb 5 (4): 916-32. Renneville Aline, Abdelali Raouf Ben, Chevret Sylvie, Nibourel Olivier, Cheok Meyling, Pautas Cécile, Duléry Rémy, Boyer Thomas, Cayuela Jean-Michel, Hayette Sandrine, Raffoux Emmanuel, Farhat Hassan, Boissel Nicolas, Terre Christine, Dombret Hervé, Castaigne Sylvie, Preudhomme Clau |
|
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia.
Leukemia 2014 Jan 28 (1): 50-8. Hou H A, Lin C C, Chou W C, Liu C Y, Chen C Y, Tang J L, Lai Y J, Tseng M H, Huang C F, Chiang Y C, Lee F Y, Kuo Y Y, Lee M C, Liu M C, Liu C W, Lin L I, Yao M, Huang S Y, Ko B S, Hsu S C, Wu S J, Tsay W, Chen Y C, Tien H |
|
Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens.
The Journal of molecular diagnostics : JMD 2014 Jan 16 (1): 56-67. Pritchard Colin C, Salipante Stephen J, Koehler Karen, Smith Christina, Scroggins Sheena, Wood Brent, Wu David, Lee Ming K, Dintzis Suzanne, Adey Andrew, Liu Yajuan, Eaton Keith D, Martins Renato, Stricker Kari, Margolin Kim A, Hoffman Noah, Churpek Jane E, Tait Jonathan F, King Mary-Claire, Walsh T |
|
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome.
Blood cancer journal 2014 4 e177. Chen T-C, Hou H-A, Chou W-C, Tang J-L, Kuo Y-Y, Chen C-Y, Tseng M-H, Huang C-F, Lai Y-J, Chiang Y-C, Lee F-Y, Liu M-C, Liu C-W, Liu C-Y, Yao M, Huang S-Y, Ko B-S, Hsu S-C, Wu S-J, Tsay W, Chen Y-C, Tien H |
|
BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.
Blood 2013 Oct 122 (18): 3169-77. Damm Frederik, Chesnais Virginie, Nagata Yasunobu, Yoshida Kenichi, Scourzic Laurianne, Okuno Yusuke, Itzykson Raphael, Sanada Masashi, Shiraishi Yuichi, Gelsi-Boyer Véronique, Renneville Aline, Miyano Satoru, Mori Hiraku, Shih Lee-Yung, Park Sophie, Dreyfus François, Guerci-Bresler Agnes, Solary Eric, Rose Christian, Cheze Stéphane, Prébet Thomas, Vey Norbert, Legentil Marion, Duffourd Yannis, de Botton Stéphane, Preudhomme Claude, Birnbaum Daniel, Bernard Olivier A, Ogawa Seishi, Fontenay Michaela, Kosmider Olivi |
|
Mutations and prognosis in primary myelofibrosis.
Leukemia 2013 Sep 27 (9): 1861-9. Vannucchi A M, Lasho T L, Guglielmelli P, Biamonte F, Pardanani A, Pereira A, Finke C, Score J, Gangat N, Mannarelli C, Ketterling R P, Rotunno G, Knudson R A, Susini M C, Laborde R R, Spolverini A, Pancrazzi A, Pieri L, Manfredini R, Tagliafico E, Zini R, Jones A, Zoi K, Reiter A, Duncombe A, Pietra D, Rumi E, Cervantes F, Barosi G, Cazzola M, Cross N C P, Tefferi |
|
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.
Leukemia 2013 Sep 27 (9): 1852-60. Meggendorfer M, Bacher U, Alpermann T, Haferlach C, Kern W, Gambacorti-Passerini C, Haferlach T, Schnittger |
|
Prognostic score including gene mutations in chronic myelomonocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Jul 31 (19): 2428-36. Itzykson Raphaël, Kosmider Olivier, Renneville Aline, Gelsi-Boyer Véronique, Meggendorfer Manja, Morabito Margot, Berthon Céline, Adès Lionel, Fenaux Pierre, Beyne-Rauzy Odile, Vey Norbert, Braun Thorsten, Haferlach Torsten, Dreyfus François, Cross Nicholas C P, Preudhomme Claude, Bernard Olivier A, Fontenay Michaela, Vainchenker William, Schnittger Susanne, Birnbaum Daniel, Droin Nathalie, Solary Er |
|
TET2, ASXL1 and EZH2 mutations in Chinese with myelodysplastic syndromes.
Leukemia research 2013 Mar 37 (3): 305-11. Wang Jieyu, Ai Xiaofei, Gale Robert Peter, Xu Zefeng, Qin Tiejun, Fang Liwei, Zhang Hongli, Pan Lijuan, Hu Naibo, Zhang Yue, Xiao Zhiji |
|
[Clinical significance of common leukemia gene mutations in patients with acute promyelocytic leukemia].
Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology 2013 Jan 21 (1): 1. Yin J, Sun AN, Tian XP, Tian H, Wang RX, Yang Z, Wang XL, Wu DP, Qiu HY, Pan JL, Cen JN, Liang JY, Chen SN |
|
ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome.
Leukemia 2013 Jan 27 (1): 82-91. Schnittger S, Eder C, Jeromin S, Alpermann T, Fasan A, Grossmann V, Kohlmann A, Illig T, Klopp N, Wichmann H-E, Kreuzer K-A, Schmid C, Staib P, Peceny R, Schmitz N, Kern W, Haferlach C, Haferlach |
|
Cooperating gene mutations in childhood acute myeloid leukemia with special reference on mutations of ASXL1, TET2, IDH1, IDH2 and DNMT3A.
Blood 2013 Jan . Liang DC, Liu HC, Yang CP, Jaing TH, Hung IJ, Yeh TC, Chen SH, Hou JY, Huang YJ, Shih YS, Huang YH, Lin TH, Shih LY |
|
Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia.
Haematologica 2013 Jan . Shih AH, Chung SS, Dolezal EK, Zhang SJ, Abdel-Wahab OI, Park CY, Nimer SD, Levine RL, Klimek VM |
|
EZH2 mutations are related to low blast percentage in bone marrow and -7/del(7q) in de novo acute myeloid leukemia.
PloS one 2013 8 (4): e61341. Wang Xiuli, Dai Haiping, Wang Qian, Wang Qinrong, Xu Yang, Wang Ying, Sun Aining, Ruan Jia, Chen Suning, Wu Dep |
|
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML).
Blood 2012 Oct 120 (15): 3080-8. Meggendorfer Manja, Roller Andreas, Haferlach Torsten, Eder Christiane, Dicker Frank, Grossmann Vera, Kohlmann Alexander, Alpermann Tamara, Yoshida Kenichi, Ogawa Seishi, Koeffler H Phillip, Kern Wolfgang, Haferlach Claudia, Schnittger Susan |
|
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Sep 30 (25): 3109-18. Mendler Jason H, Maharry Kati, Radmacher Michael D, Mrózek Krzysztof, Becker Heiko, Metzeler Klaus H, Schwind Sebastian, Whitman Susan P, Khalife Jihane, Kohlschmidt Jessica, Nicolet Deedra, Powell Bayard L, Carter Thomas H, Wetzler Meir, Moore Joseph O, Kolitz Jonathan E, Baer Maria R, Carroll Andrew J, Larson Richard A, Caligiuri Michael A, Marcucci Guido, Bloomfield Clara |
|
Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms.
Genes, chromosomes & cancer 2012 Aug 51 (8): 743-55. Brecqueville Mandy, Rey Jérôme, Bertucci François, Coppin Emilie, Finetti Pascal, Carbuccia Nadine, Cervera Nathalie, Gelsi-Boyer Véronique, Arnoulet Christine, Gisserot Olivier, Verrot Denis, Slama Borhane, Vey Norbert, Mozziconacci Marie-Joelle, Birnbaum Daniel, Murati An |
|
Rapid Screening of ASXL1, IDH1, IDH2, and c-CBL Mutations in de Novo Acute Myeloid Leukemia by High-Resolution Melting.
The Journal of molecular diagnostics : JMD 2012 Aug . Ibañez M, Such E, Cervera J, Luna I, Gomez-Seguí I, Lopez-Pavía M, Dolz S, Barragan E, Fuster O, Llop M, Rodriguez-Veiga R, Avaria A, Oltra S, Leonor Senent M, Moscardó F, Montesinos P, Martinez-Cuadrón D, Martín G, Sanz MA |
|
Acute myeloid leukemia with myelodysplasia-related changes are characterized by a specific molecular pattern with high frequency of ASXL1 mutations.
American journal of hematology 2012 Jul 87 (7): 659-62. Devillier Raynier, Gelsi-Boyer Véronique, Brecqueville Mandy, Carbuccia Nadine, Murati Anne, Vey Norbert, Birnbaum Daniel, Mozziconacci Marie-Joël |
|
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes.
Blood 2012 Apr 119 (15): 3578-84. Thol Felicitas, Kade Sofia, Schlarmann Carola, Löffeld Patrick, Morgan Michael, Krauter Jürgen, Wlodarski Marcin W, Kölking Britta, Wichmann Martin, Görlich Kerstin, Göhring Gudrun, Bug Gesine, Ottmann Oliver, Niemeyer Charlotte M, Hofmann Wolf-Karsten, Schlegelberger Brigitte, Ganser Arnold, Heuser Micha |
|
Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value.
Haematologica 2012 Mar 97 (3): 388-92. Pratcorona Marta, Abbas Saman, Sanders Mathijs A, Koenders Jasper E, Kavelaars François G, Erpelinck-Verschueren Claudia A J, Zeilemakers Annelieke, Löwenberg Bob, Valk Peter J |
|
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.
The New England journal of medicine 2012 Mar 366 (12): 1079-89. Patel Jay P, Gönen Mithat, Figueroa Maria E, Fernandez Hugo, Sun Zhuoxin, Racevskis Janis, Van Vlierberghe Pieter, Dolgalev Igor, Thomas Sabrena, Aminova Olga, Huberman Kety, Cheng Janice, Viale Agnes, Socci Nicholas D, Heguy Adriana, Cherry Athena, Vance Gail, Higgins Rodney R, Ketterling Rhett P, Gallagher Robert E, Litzow Mark, van den Brink Marcel R M, Lazarus Hillard M, Rowe Jacob M, Luger Selina, Ferrando Adolfo, Paietta Elisabeth, Tallman Martin S, Melnick Ari, Abdel-Wahab Omar, Levine Ross |
|
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.
Blood 2011 Dec 118 (26): 6920-9. Metzeler Klaus H, Becker Heiko, Maharry Kati, Radmacher Michael D, Kohlschmidt Jessica, Mrózek Krzysztof, Nicolet Deedra, Whitman Susan P, Wu Yue-Zhong, Schwind Sebastian, Powell Bayard L, Carter Thomas H, Wetzler Meir, Moore Joseph O, Kolitz Jonathan E, Baer Maria R, Carroll Andrew J, Larson Richard A, Caligiuri Michael A, Marcucci Guido, Bloomfield Clara |
- Page last reviewed:Jul 30, 2019
- Page last updated:Nov 14, 2019
- Content source: